Evidence map›Paper›PMID 39683277›Full record

ArticleNanomaterials (Basel, Switzerland)2024

Toward Standardization of a Lung New Approach Model for Toxicity Testing of Nanomaterials.

Elisabeth Elje, Laura M A Camassa, Sergey Shaposhnikov, Kristine Haugen Anmarkrud, Øivind Skare, Asbjørn M Nilsen, Shan Zienolddiny-Narui, Elise Rundén-Pran

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Application of the Comet Assay in Advanced In Vitro Models.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Elisabeth EljeNorwegian Institute for Air Research, 2027 Kjeller, Norway.ORCID 0000-0002-1983-3358
Laura M A CamassaNational Institute of Occupational Health in Norway, 0033 Oslo, Norway.ORCID 0000-0002-5041-942X
Sergey ShaposhnikovNorGenoTech, 0349 Oslo, Norway.
Kristine Haugen AnmarkrudNational Institute of Occupational Health in Norway, 0033 Oslo, Norway.
Øivind SkareNational Institute of Occupational Health in Norway, 0033 Oslo, Norway.ORCID 0000-0001-8043-2820
Asbjørn M NilsenFaculty of Medicine and Health Sciences, Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7491 Trondheim, Norway.
Shan Zienolddiny-NaruiNational Institute of Occupational Health in Norway, 0033 Oslo, Norway.ORCID 0000-0001-9747-9625
Elise Rundén-PranNorwegian Institute for Air Research, 2027 Kjeller, Norway.ORCID 0000-0002-5541-4513

Funding

NanoBioReal 288768
6 · The paper itself

Abstract

This study represents an attempt toward the standardization of pulmonary NAMs and the development of a novel approach for toxicity testing of nanomaterials. Laboratory comparisons are challenging yet essential for identifying existing limitations and proposing potential solutions. Lung cells cultivated and exposed at the air-liquid interface (ALI) more accurately represent the physiology of human lungs and pulmonary exposure scenarios than submerged cell and exposure models. A triculture cell model system was used, consisting of human A549 lung epithelial cells and differentiated THP-1 macrophages on the apical side, with EA.hy926 endothelial cells on the basolateral side. The cells were exposed to silver nanoparticles NM-300K for 24 h. The model used here showed to be applicable for assessing the hazards of nanomaterials and chemicals, albeit with some limitations. Cellular viability was measured using the alamarBlue assay, DNA damage was assessed with the enzyme-modified comet assay, and the expression of 40 genes related to cell viability, inflammation, and DNA damage response was evaluated through RT

Indexed as

A549ALIgenotoxicityNAMsNM-300Ktriculture

Identifiers

PMID39683277
PMCPMC11643904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.